Annual report pursuant to Section 13 and 15(d)

Insider Trading Arrangements

v3.24.4
Insider Trading Arrangements
 3 Months Ended 12 Months Ended
Dec. 31, 2024
shares
Dec. 31, 2024
shares
Trading Arrangements, by Individual    
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Dr. Theodore Tewksbury [Member]    
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement   On November 14, 2024, Dr. Theodore Tewksbury, a director of the Company, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 6,071 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until November 15, 2025, or earlier if all transactions under the trading arrangement are completed.
Name Dr. Theodore Tewksbury  
Title director  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 14, 2024  
Expiration Date November 15, 2025  
Arrangement Duration 366 days  
Aggregate Available 6,071 6,071